# MedData Infrastructure Due Diligence Report

## Company Overview

MedData, founded in 2017, is a leading healthcare technology platform that processes medical claims and provides real-time analytics for healthcare providers and payers. The company's SaaS platform handles over $2.3B in annual claims volume for 450+ healthcare organizations across 38 states.

**Core Products:**
- ClaimStream: Real-time claims processing and adjudication platform
- Analytics360: Healthcare data analytics and reporting suite
- Provider Portal: Patient management and billing dashboard
- API Gateway: Healthcare data integration platform for partners

**Customer Base:** Mid-to-large healthcare providers, regional payers, and healthcare technology companies seeking claims processing infrastructure.

## Growth Timeline & Technical Evolution

**2017-2018: Startup Phase**
- Founded by Dr. Sarah Chen (CEO) and Michael Torres (CTO)
- Initial team of 8 engineers, $3M seed funding
- Built MVP on AWS with basic security controls
- Single production account, founder admin access patterns established
- First major customer: Regional healthcare system processing 50K claims/month

**2019: Rapid Scaling**
- Series A: $18M led by HealthTech Ventures
- Team grew from 8 to 45 engineers
- Black Friday 2019 outage led to emergency IAM changes that were never reverted
- Acquired smaller claims processing startup, inheriting their technical debt
- Revenue: $2.8M ARR, processing 2M claims/month

**2020: COVID-19 Acceleration**
- Series B: $45M amid pandemic-driven healthcare digitization
- Engineering team doubled to 90 as demand surged 400%
- Remote work transition opened SSH access globally (temporary became permanent)
- Built analytics platform in 6 weeks for Series B demo - security shortcuts taken
- Revenue: $12M ARR, 15M claims/month

**2021-2022: Enterprise Expansion**
- Series C: $85M for enterprise sales expansion
- Engineering scaled to 180, first dedicated security hire
- Multi-tenant architecture rebuild, but legacy systems remained
- SOC 2 Type I compliance achieved, Type II in progress
- Revenue: $38M ARR, 45M claims/month

**2023: Market Leadership**
- Current revenue: $67M ARR (80% growth YoY)
- Engineering team: 310 across 15 AWS accounts
- Processing 85M claims/month for Fortune 500 customers
- HITRUST certification initiated, completion expected Q2 2024

## Current Technical Architecture

**Infrastructure Scale:**
- 15 AWS accounts across production, staging, and development environments
- Kubernetes clusters running 200+ microservices
- DynamoDB handling 500M+ queries/day
- S3 storing 45TB of healthcare data with PHI classification
- Lambda processing 2M+ events daily

**Engineering Organization:**
- Platform Engineering: 45 engineers (infrastructure, DevOps, security)
- Product Engineering: 180 engineers (8 product teams)
- Data Engineering: 35 engineers (analytics, ETL, ML)
- Security Team: 12 engineers (established late 2021)
- Site Reliability: 18 engineers

**Technology Stack:**
- Containerized microservices on self-managed Kubernetes
- Python/Node.js applications with PostgreSQL and DynamoDB
- React frontends with mobile-first design
- Event-driven architecture using SQS/SNS
- Real-time processing with Lambda and DynamoDB Streams

## Risk Analysis: Technical Debt from Hypergrowth

### IAM Overprivilege (Critical Risk)

The most significant security risk stems from MedData's early-stage AWS setup that was never properly refined during hypergrowth phases. The founding team established broad admin access patterns in 2017 when the company was 3 engineers building an MVP. As the team scaled 100x to 300+ engineers, these overprivileged patterns persisted and expanded.

**Root Causes:**
- **Founder Admin Rights**: CEO account retains full AWS admin access from startup days, despite transitioning to business-focused role in 2020
- **Emergency Decisions**: Black Friday 2019 outage led to overly permissive cross-account trust policies that were implemented as emergency fixes but never properly scoped
- **CI/CD Shortcuts**: Service accounts have full admin access because DevOps team was overwhelmed during Series B scaling and chose expedient over secure solutions
- **Acquisition Technical Debt**: 2019 acquisition of claims processing startup brought ETL systems with wildcard S3 policies that were never refactored

**Business Impact**: These overprivileged patterns mean a single compromised credential could grant attackers access to all PHI data and critical infrastructure, representing existential risk for a healthcare company.

### Secrets Management (High Risk)

MedData's secrets management practices reflect the common pattern of security being deprioritized during rapid growth phases, particularly around the Series A and Series B fundraising periods when engineering velocity was paramount.

**Root Causes:**
- **Pre-Security Team Era**: Database credentials were hardcoded in Lambda environment variables during 2019 migration from on-premises, before security team existed
- **Contractor Handoff Issues**: Claims ETL system built by external contractor team in 2018 contains multiple hardcoded secrets; knowledge transfer was incomplete when contract ended
- **Revenue Pressure**: Stripe payment integration bypassed security review process due to pressure to launch billing features for enterprise customers
- **Lost Institutional Knowledge**: Legacy partner API keys from 2018 integrations were never rotated after original engineer departed

**Business Impact**: Exposed credentials could enable unauthorized access to PHI data, financial information, and partner systems, creating HIPAA violation risk and potential seven-figure regulatory fines.

### Network Security (Medium Risk)

Network security issues primarily stem from the COVID-19 remote work transition and development team productivity pressures rather than fundamental architectural problems.

**Root Causes:**
- **COVID-19 Remote Transition**: SSH security groups were opened globally in March 2020 as emergency remote access measure; restriction was never implemented as team remained distributed
- **Data Center Migration**: Legacy PostgreSQL database port remained open to internet after migration from on-premises data center, originally opened for external ETL vendor access
- **Developer Productivity**: Development environment security group was opened broadly by frustrated junior engineer; senior team was focused on production scaling issues during Series B growth phase

**Business Impact**: Network exposure creates potential entry points for attackers but is partially mitigated by VPC architecture and application-layer security controls.

## Acquisition Considerations

### Investment Requirements

A PE buyer should budget $2-3M over 18 months for comprehensive security remediation:

**Immediate (0-6 months): $1.2M**
- Security team expansion (4 additional engineers)
- IAM policy audit and least-privilege implementation
- Secrets management migration to AWS Secrets Manager with rotation
- Network security group remediation
- SOC 2 Type II and HITRUST certification completion

**Medium-term (6-12 months): $1.1M**
- Zero-trust network architecture implementation
- Infrastructure as Code adoption for security consistency
- Automated security scanning and compliance monitoring
- Incident response and disaster recovery program enhancement

**Long-term (12-18 months): $700K**
- Legacy system retirement and modern architecture migration
- Advanced threat detection and SIEM implementation
- Security training and culture development across engineering

### Strategic Value Proposition

Despite security technical debt, MedData represents a compelling acquisition target:

**Market Position**: Clear leader in mid-market healthcare claims processing with 80% annual growth and expanding enterprise customer base

**Technology Moats**: Real-time processing capabilities and healthcare data expertise create significant barriers to entry

**Scalable Architecture**: Modern microservices foundation can support 10x growth with proper security investment

**Regulatory Momentum**: Ongoing HITRUST certification and SOC 2 compliance demonstrate security investment trajectory

**Team Quality**: Strong engineering leadership and established security team provide foundation for remediation execution

The key insight for PE buyers is that MedData's security issues are primarily operational rather than architectural - they stem from hypergrowth management challenges rather than fundamental technology choices. With proper investment in security tooling, processes, and team expansion, these risks are highly addressable while preserving the company's competitive advantages and growth trajectory.

The security technical debt should be viewed as a manageable remediation project rather than a deal-breaking fundamental flaw, particularly given MedData's strong market position and the healthcare industry's increasing focus on digital infrastructure security.